檢索結果 - Keith Bodger
- Showing 1 - 10 results of 10
-
1
Helicobacter pyloriand gastric inflammation 由 Keith Bodger, Jean E. Crabtree
出版 1998Revisão -
2
-
3
-
4
-
5
-
6
-
7
P245 Biologics Sequencing in Clinical Units (BISCUITS): Comparing outcomes in Crohn’s disease patients on second-line biologics 由 Giulia Bartalucci, Frederick R. Taylor, C. Gleave, Liz Dobson, Keith Bodger, Susanna Dodd, Stuart Bloom, Alun Passey, R Nissinen, Daniel Wirth, Darian Andreas, J Lee, Fraser Cummings
出版 2024Artigo -
8
The Role of Matrix Metalloproteinase-7 in Redefining the Gastric Microenvironment in Response to Helicobacter pylori 由 Catherine McCaig, Cédric Duval, Elaine Hemers, Islay Steele, D. Mark Pritchard, S.M.C. Przemeck, R. Dimaline, Suhail Ahmed, Keith Bodger, David Kerrigan, Timothy C. Wang, Graham J. Dockray, Andrea Varró
出版 2006Artigo -
9
Real-world assessment of effectiveness and safety of filgotinib in 286 patients with ulcerative colitis in 9 UK centres 由 David Young, Sohail Rahmany, Deborah R. Taylor, E. A. Davis, Michael Colwill, Sonia Kalyanji Mehta, Roisin Campbell, Karl Hazel, Karishma Sethi-Arora, Susan Ritchie, Ashley Heinson, Helen Moyses, Keith Bodger, Emma Johnston, Lucy Hicks, Anjan Dhar, Jimmy K. Limdi, Rachel Cooney, John Paul Seenan, Kamal Patel, Alissa Walsh, Fraser Cummings
出版 2025Artigo -
10
Developing a Standard Set of Patient-Centred Outcomes for Inflammatory Bowel Disease—an International, Cross-disciplinary Consensus 由 Andrew Kim, Charlotte Roberts, Brian G. Feagan, Rupa Banerjee, Willem A. Bemelman, Keith Bodger, Marc Derieppe, Axel Dignaß, Richard Driscoll, Ray Fitzpatrick, Janette Gaarentstroom-Lunt, Peter Higgins, Paulo Gustavo Kotze, Jillian Meissner, Marian O’Connor, Zhihua Ran, Corey A. Siegel, Helen Terry, Welmoed K. van Deen, C. Janneke van der Woude, Alandra Weaver, Suk‐Kyun Yang, Bruce E. Sands, Séverine Vermeire, Simon Travis
出版 2017Revisão
相關主題
Internal medicine
Medicine
Disease
Intensive care medicine
Nursing
Quality of life (healthcare)
Helicobacter pylori
Mathematics
Ulcerative colitis
Cohort
Crohn's disease
Cytokine
Economic growth
Economics
Gastric mucosa
Gastroenterology
Health care
Immunology
Inflammation
Inflammatory bowel disease
Infliximab
Patient-reported outcome
Psychiatry
Statistics
Stomach
Adalimumab
Antigen
Anxiety
Biochemistry
Biology